All In MedTech

FDA Clearance Tracker · P950032-S022

APLIGRAF(GRAFTSKIN)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 26, 2001 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 26, 2001

Approved

Time to decision

99 days

Received Jan 17, 2001. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P950032-S022
Device name
APLIGRAF(GRAFTSKIN)
Applicant location
Canton, MA
Received
Jan 17, 2001
Decided
Apr 26, 2001
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P950032

Device type

Device class
Class III

Every decision under product code MGR

FDA's approval statement

As written in FDA's record.

APPROVAL FOR REPLACEMENT OF THE SOYBEAN TRYPSIN INHIBITOR REAGENT IN APLIGRAF MANUFACTURE WITH THE NEWLY DEFINED TRYPSIN QUENCHING MEDIUM.

Source documents

Other decisions for Organogenesis, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.